Brought to you by 
MolMed completes €56.2mm IPO on Borsa Italiana
30 Mar 2021
Executive Summary
MolMed SPA (primarily oncology pharmaceuticals) grossed €56.2mm ($82.3mm) in its initial public offering on Borsa Italiana, the Italian stock exchange. It sold 26.1mm shares at €2.15 each, the bottom of its €2.15-2.75 range announced earlier this month.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Vaccines
-
Drug Delivery
- Macromolecule
-
Biotechnology
- Gene Therapy, Cell Therapy
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
MolMed completes €56.2mm IPO on Borsa Italiana
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice